Modulation of pilocarpine-induced seizures by cannabinoid receptor 1

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Kow, Rebecca L ^a   Jiang, Kelly ^a   Naydenov, Alipi V ^a   Le, Joshua H ^a   Stella, Nephi ^a   Nathanson, Neil M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; CYCLINE; ENDOCANNABINOID; PILOCARPINE; 3-(2-HYDROXY-4-(1,1-DIMETHYLHEPTYL)PHENYL)-4-(3-HYDROXYPROPYL)CYCLOHEXANOL; CYCLOHEXANOL DERIVATIVE; MUSCARINIC AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; GENE DELETION; IMMUNOFLUORESCENCE; MALE; MOUSE; NONHUMAN; RECEPTOR INTRINSIC ACTIVITY; SEIZURE; ANIMAL; CHEMICALLY INDUCED; GENETICS; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; CYCLOHEXANOLS; MALE; MICE; MICE, KNOCKOUT; MUSCARINIC AGONISTS; PILOCARPINE; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, CANNABINOID, CB1; SEIZURES;

EID: 84899677342     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095922     Document Type: Article

References (35)

1. Eglen RM (2006) Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function. Auton Autacoid Pharmacol 26: 219-233.
2. Nathanson NM (2000) A multiplicity of muscarinic mechanisms: Enough signaling pathways to take your breath away. Proc Natl Acad Sci USA 97: 6245-6247.
3. Bubser M, Byun N, Wood MR, Jones CK (2012) Muscarinic receptor pharmacology and circuitry for the modulation of cognition. In: Fryer AD, Christopoulos A, Nathanson NM, editors. Handb Exp Pharmacol. Berlin: Springer Berlin Heidelberg. 121-166.
4. Newman EL, Gupta K, Climer JR, Monaghan CK, Hasselmo ME (2012) Cholinergic modulation of cognitive processing: insights drawn from computational models. Front Behav Neurosci 6: 24. doi: 10.3389/fnbeh.2012.00024.
5. 3H]N- methylscopolamine in central nervous system of muscarinic acetylcholine receptor knockout mice. Brain Res Mol Brain Res 133: 6-11.
6. Hamilton SE, Loose MD, Levey AI, Hille B, McKnight GS, et al. (1997) Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc Natl Acad Sci USA 94: 13311-13316. (Pubitemid 27518518)
7. Anagnostaras SG, Murphy GG, Hamilton SE, Mitchell SL, Rahnama NP, et al. (2003) Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat Neurosci 6: 51-58. (Pubitemid 36026332)
8. 1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models. J Neurosci 20: 8532-8544.
9. Turski L, Ikonomidou C, Turski WA, Bortolotto ZA, Cavalheiro EA (1989) Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 3: 154-171. (Pubitemid 19073451)
10. Mello LE, Cavalheiro EA, Tan AM, Kupfer WR, Pretorius JK, et al. (1993) Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 34: 985-995. (Pubitemid 24004233)
11. Parent JM, Yu TW, Leibowitz RT, Geschwind DH, Sloviter RS, et al. (1997) Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J Neurosci 17: 3727-3738. (Pubitemid 27200597)
12. Turski WA, Cavalheiro EA, Bortolotto ZA, Mello LM, Schwarz M, et al. (1984) Seizures produced by pilocarpine in mice: A behavioral, electroencephalographic and morphological analysis. Brain Res 321: 237-253. (Pubitemid 15203890)
13. Clifford DB, Olney JW, Maniotis A, Collins RC, Zorumski CF (1987) The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizures. Neuroscience 23: 953-968. (Pubitemid 18014408)
14. 1 receptors in cannabinoid anticonvulsant effects. Eur J Pharmacol 428: 51-57.
15. Wallace MJ, Blair RE, Falenski KW, Martin BR, DeLorenzo RJ (2003) The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J Pharmacol Exp Ther 307: 129-137. (Pubitemid 37151898)
16. Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, et al. (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302: 84-88. (Pubitemid 37210691)
17. Hofmann ME, Frazier CJ (2013) Marijuana, endocannabinoids, and epilepsy: Potential and challenges for improved therapeutic intervention. Exp Neurol 244: 43-50.
18. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54: 161-202. (Pubitemid 34575709)
19. Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410: 588-592. (Pubitemid 32267203)
20. 3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus. Eur J Neurosci 18: 109-116.
21. 3-mediated indirect suppression through endocannabinoid signalling. Eur J Neurosci 19: 2682-2692.
22. 2+dependency for triggering retrograde endocannabinoid signal. Neuron 45: 257-268.
23. Falenski KW, Blair RE, Sim-Selley LJ, Martin BR, DeLorenzo RJ (2007) Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy. Neuroscience 146: 1232-1244. (Pubitemid 46694119)
24. 1receptor expression following pilocarpine-induced status epilepticus. Brain Res 1262: 64-72.
25. Karlócai MR, Tóth K, Watanabe M, Ledent C, Juhász G, et al. (2011) Redistribution of CB1 cannabinoid receptors in the acute and chronic phases of pilocarpine-induced epilepsy. PLoS One 6: e27196. Doi: 10.1371/journal.-pone.0027196.
26. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, et al. (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534. (Pubitemid 34851398)
27. Martin BR, Compton DR, Thomas BF, Prescott WR, Little PJ, et al. (1991) Behavioral, biochemical, and molecularmodeling evaluations of cannabinoid analogs. Pharmacol Biochem Behav. 40: 471-478.
28. Von Bohlen O, Halbach O (2011) Immunohistological markers for proliferative events, gliogenesis, and neurogenesis within the adult hippocampus. Cell Tissue Res 345: 1-19.
29. Ledergerber D, Fritschy JM, Kralic JE (2005) Impairment of dentate gyrus neuronal progenitor cell differentiation in a mouse model of temporal lobe epilepsy. Exp Neurol 199: 130-142.
30. Schmued LC, Hopkins KJ (2000) Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874: 123-130.
31. Monory K, Blaudzun H, Massa F, Kaiser N, Lemberger T, et al. (2007) Genetic dissection of behavioural and autonomic effects of Delta(9)- tetrahydrocannabinol in mice. PLoS Biol 5: e269.
32. Wiley JL, Martin BR (2003) Cannabinoid pharmacological properties common to other centrally acting drugs. Eur J Pharmacol 471: 185-193. (Pubitemid 36776413)
33. 1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis. J Biol Chem 282: 23892-23898.
34. Maglóczky Z, Tóth K, Karlócai R, Nagy S, Eröss L, et al. (2010) Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and humans. Epilepsia 51: 115-120.
35. 1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J Neurosci 28: 2976-2990.